, an insider at Relmada Therapeutics, Inc., Buys Shares Worth $1.67 million

Relmada Therapeutics, Inc. (RLMD) disclosed that , who holds the position of insider at the company, was involved in buying 400,000 shares, per a Form 4 filing with the SEC.

The transaction was executed at a price of $4.18 per share, for a total value of approximately $1.67 million.

Company insiders are required to disclose changes in their stock ownership to the SEC on Form 4, typically within two business days of the trade.

Purchases by company insiders are one of several signals investors monitor, alongside earnings results and broader sector trends.